MAXHEALTHBSEMax Healthcare Institute LtdMediumNeutral
Announced Thu, 21 May · 16:52 IST

Re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director

Director Flagged GovernanceManagement Changes View source PDF

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.5%1-day move
₹1093.15
prior close
₹1068.25
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.7-3.9-4.7-4.6-8.5-9.2-9.0-11.7-13.7-11.7-5.8-0.0-1.1
Up moveDown movePending
AI summary

Max Healthcare's board meeting on May 21, 2026 approved multiple items including audited Q4 and FY2026 financial results showing consolidated revenue of Rs 8,37,345 lakhs (up 19% YoY) and standalone revenue of Rs 2,87,445 lakhs. The board recommended a final dividend of Rs 2 per share (20% of face value). Key governance items include the re-appointment of Mr. Anil Kumar Bhatnagar (who turned 75 in August 2025) as Non-Executive Non-Independent Director for 3 years from October 2026 to September 2029, subject to shareholder approval at the AGM. The board also approved construction of a new ~712-bed hospital in Lucknow, re-classification of Radiant Life Care Hospital Foundation from Promoter Group to Public category, and shifting the registered office from Mumbai to Gurugram.

Likely market impact

The re-appointment of an over-75 director requires shareholder approval but is not unusual; the company also announced expansion plans and a dividend, which are positive signals for investors.